Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119506) titled 'A Real-World Study on the Efficacy and Safety of Ezetimibe Combined with Rosuvastatin in the Treatment of Elderly Patients with ASCVD' on Feb. 28.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Ansteel Group General Hospital

Condition: Elderly patients with ASCVD

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Interventional group:130;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=304516

Published by HT Digital Content Services with permission from Health Daily Dig...